ArticleCureus2026
Reverse Total Shoulder Arthroplasty in a 25-Year-Old Woman With Seropositive Rheumatoid Arthritis After Prior Age-Based Surgical Deferral.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reverse total shoulder arthroplasty (RTSA) in very young adults with rheumatoid arthritis (RA) is uncommon because of concerns regarding implant longevity and lifetime revision burden, and outcomes data in patients younger than 30 years remain limited. We report the case of a 25-year-old woman with seropositive RA who developed rapid, destructive monoarticular involvement of the right shoulder despite treatment with disease-modifying antirheumatic drugs (DMARDs) and biologic therapy. Imaging demonstrated complete glenohumeral joint space obliteration, humeral head collapse, erosive changes, and rotator cuff insufficiency. An initial shoulder surgeon declined arthroplasty based on her age and anticipated revision risk. Following staged diagnostic arthroscopy, definitive RTSA was performed in December 2023 without complication. At four months, near-full active forward elevation was restored. At two-year follow-up, the American Shoulder and Elbow Surgeons (ASES) score was 80/100 (pain 3/10; activities of daily living 27/30), and the Single Assessment Numeric Evaluation (SANE) score was 95%. No instability, infection, or mechanical failure occurred. This case demonstrates that RTSA can provide excellent early and mid-term functional outcomes in carefully selected very young patients with end-stage inflammatory shoulder disease and may help inform surgical decision-making when age is the primary barrier to intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.